Morgan Stanley Sees LifePoint Hospitals as Riding Medicaid Expansion in 2014

In a report published Tuesday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT ). In the report, Morgan Stanley noted, “LPNT expects 2014 Adj. EBITDA of $560M to $590M inclusive of reform which implies growth of 4.3% to 9.9% Y/Y. Guidance compares with MS